Pharma's Market
SPECIAL REPORT
MOST SHARED
- How to Date a Wall Street Man
- Europe Shares End Lower, Hit by New Greek Concerns
- Unions Launch Strike in Greece
- 5 Hedge Funds’ Top Stocks Soar After 2011 Rout
- Bill Murray's View on the Economy
- The World's Best Beers
- Steelers' Antonio Brown Spends Super Bowl Week with Twitter Fan Turned BFF
- Spent Keurig K-Cups Filling Up U.S. Landfills
- Greece Austerity Deal Runs Into Trouble Once Again
- Jobs You Can Do Forever
- The Real Reason Behind Bank of America’s Rally
- 5 Hedge Funds’ Top Stocks Soar After 2011 Rout
- This Valentine’s Day Love Is Served on a Silver Platter
- CEO to CEO: Our Roles Are Changing
- Clint Eastwood ‘Surprised’ by Reaction to Chrysler's ‘Halftime in America’ Ad
- Bulls Check In to Community Health
- Bank of America’s Worst-Case Scenario Gets More Real
- Tesla Unveils First SUV: Model X
- New York Fashion Week Hits the Runway as Colors Pop
- Greece Austerity Deal Runs Into Trouble Once Again
- Why Greece Will Default, Leave Eurozone
- Housing Still Hurting Consumers, Economy: Bernanke
- Get Ready for $5 Gas This Year: Ex-Shell CEO
- Diamond Investing: Why It's Not for the Faint of Heart
- Obama Backs Down on Birth Control Plan
- Israel Likely to Bomb Iran This Year: Political Analyst
- The World's Best Beers
- Users of Citibank Bill-Pay App Charged Twice
RSS FEED
Amgen's Visit From The "Tooth Fairy" (By Way Of Root Canal?)
Text Size 
Reporter
 |
CNBC.com |
I'm outside the Four Seasons Hotel in Westlake Village, CA, where the get-together takes place this afternoon. Reporters will be allowed inside to take notes, but we can't use any recording equipment--i.e. a TV camera.
Anyway, Steve Silverman who has owned AMGN [AMGN
Loading...
()
] shares for about two decades and has gotten "very rich" off the investment, was the self-appointed ringleader of a shareholder protest of sorts.
On message boards, in chat rooms and in the media Mr. Silverman was trying to spearhead a campaign to oust Chairman and CEO Kevin Sharer and the Board of Directors. The 70-year-old retired insurance man admits it was a long shot.
He's upset over the stock's decline and what he sees as a series of management missteps. Amgen defends Sharer saying the company has grown "dramatically" on his watch.
Yesterday afternoon Mr. Silverman sent me an email saying he won't be speaking out at the meeting after all. He explains he has a toothache that requires emergency root canal today.
He added that he spoke to Sharer on the phone yesterday for almost 90 minutes and concluded, "He is interesting but definitely has his views and positions on the company. I still would not vote for him."
An Amgen spokesman confirms the phone call took place, but says that it didn't last quite as long.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes
